These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2379537)

  • 1. Nonlinear kinetics of propafenone metabolites in healthy man.
    Vozeh S; Haefeli W; Ha HR; Vlcek J; Follath F
    Eur J Clin Pharmacol; 1990; 38(5):509-13. PubMed ID: 2379537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent electrophysiologic effects of the major metabolites of propafenone in canine Purkinje fibers.
    Thompson KA; Iansmith DH; Siddoway LA; Woosley RL; Roden DM
    J Pharmacol Exp Ther; 1988 Mar; 244(3):950-5. PubMed ID: 3252042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A sensitive quantitative assay for the determination of propafenone and two metabolites, 5-hydroxypropafenone and N-depropylpropafenone, in human K2EDTA plasma using LC-MS/MS with ESI operated in positive mode.
    Patel H; Ghoghari A; Bhatt C; Shah S; Jha A; Desai N; Srinivas NR
    Biomed Chromatogr; 2017 Oct; 31(10):. PubMed ID: 28261841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ECG changes and plasma concentrations of propafenone and its metabolites in a case of severe poisoning.
    Fonck K; Haenebalcke C; Hemeryck A; Belpaire F; Jordaens L; Calle P; Buylaert W
    J Toxicol Clin Toxicol; 1998; 36(3):247-51. PubMed ID: 9656983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and pharmacodynamic evaluation of propafenone in patients with ventricular arrhythmia. Propafenone Research Group.
    Zoble RG; Kirsten EB; Brewington J
    Clin Pharmacol Ther; 1989 May; 45(5):535-41. PubMed ID: 2721109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the pharmacodynamic effects of intravenous and oral propafenone.
    Haefeli EW; Vozeh S; Ha HR; Follath F
    Clin Pharmacol Ther; 1990 Sep; 48(3):245-54. PubMed ID: 2401123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic characterization of the antiarrhythmic drug diprafenone in man.
    Trenk D; Wagner F; Sachs W; Jähnchen E
    Eur J Clin Pharmacol; 1989; 37(3):313-6. PubMed ID: 2612546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous and oral propafenone for treatment of tachycardia in infants and children: pharmacokinetics and clinical response.
    Ito S; Gow R; Verjee Z; Giesbrecht E; Dodo H; Freedom R; Tonn GR; Axelson JE; Zalzstein E; Rosenberg HC; Koren G
    J Clin Pharmacol; 1998 Jun; 38(6):496-501. PubMed ID: 9650538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pharmacokinetics between a microdose and therapeutic dose for clarithromycin, sumatriptan, propafenone, paracetamol (acetaminophen), and phenobarbital in human volunteers.
    Lappin G; Shishikura Y; Jochemsen R; Weaver RJ; Gesson C; Brian Houston J; Oosterhuis B; Bjerrum OJ; Grynkiewicz G; Alder J; Rowland M; Garner C
    Eur J Pharm Sci; 2011 Jun; 43(3):141-50. PubMed ID: 21540108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of propafenone metaboliser phenotype from plasma and urine excretion data.
    Latini R; Belloni M; Bernasconi R; Cappiello E; Giani P; Landolina M; Leopaldi D; Castel JM
    Eur J Clin Pharmacol; 1992; 42(1):111-4. PubMed ID: 1541308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of glucuronides of propafenone and 5-hydroxypropafenone by Sepharose-bound uridine 5'-diphosphoglucuronyltransferase.
    Neidlein R; Wu M; Hege HG
    Arzneimittelforschung; 1988 Sep; 38(9):1257-62. PubMed ID: 3146983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of (R/S)-propafenone and its metabolites as substrates and inhibitors of P-glycoprotein.
    Bachmakov I; Rekersbrink S; Hofmann U; Eichelbaum M; Fromm MF
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Mar; 371(3):195-201. PubMed ID: 15900513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonlinear pharmacokinetics of propafenone in rats and humans: application of a substrate depletion assay using hepatocytes for assessment of nonlinearity.
    Komura H; Iwaki M
    Drug Metab Dispos; 2005 Jun; 33(6):726-32. PubMed ID: 15743979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relative potency of major metabolites and enantiomers of propafenone in an experimental reperfusion arrhythmia model.
    Oti-Amoako K; Vozeh S; Ha HR; Follath F
    J Cardiovasc Pharmacol; 1990 Jan; 15(1):75-81. PubMed ID: 1688986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetically-determined interaction between propafenone and low dose quinidine: role of active metabolites in modulating net drug effect.
    Funck-Brentano C; Kroemer HK; Pavlou H; Woosley RL; Roden DM
    Br J Clin Pharmacol; 1989 Apr; 27(4):435-44. PubMed ID: 2719900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of propafenone during acute and chronic administration.
    Giani P; Landolina M; Giudici V; Bianchini C; Ferrario G; Marchi S; Riva E; Latini R
    Eur J Clin Pharmacol; 1988; 34(2):187-94. PubMed ID: 3383990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of buccal absorption of propafenone single oral loading dose in healthy humans.
    Sasaki S; Koumi S; Sato R; Murata M; Nagasawa K; Sakurai E; Hikichi N; Hayakawa H
    Gen Pharmacol; 1998 Oct; 31(4):589-91. PubMed ID: 9792220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequences.
    Siddoway LA; Thompson KA; McAllister CB; Wang T; Wilkinson GR; Roden DM; Woosley RL
    Circulation; 1987 Apr; 75(4):785-91. PubMed ID: 3829342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of CYP2D6 polymorphisms on the pharmacokinetics of propafenone and its two main metabolites.
    Rouini MR; Afshar M
    Therapie; 2017 Jun; 72(3):373-382. PubMed ID: 28087064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous determination of serum propafenone and its metabolites using high-performance liquid chromatography.
    Shirayama Y; Doki K; Sekiguchi Y; Aonuma K; Kohda Y; Homma M
    Biomed Chromatogr; 2018 Feb; 32(2):. PubMed ID: 28929504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.